"Primaquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
| Descriptor ID |
D011319
|
| MeSH Number(s) |
D03.633.100.810.050.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Primaquine".
Below are MeSH descriptors whose meaning is more specific than "Primaquine".
This graph shows the total number of publications written about "Primaquine" by people in this website by year, and whether "Primaquine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 5 | 5 | 10 |
| 2018 | 11 | 4 | 15 |
| 2019 | 4 | 4 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Primaquine" by people in Profiles.
-
Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic. S Afr Med J. 2020 11 23; 111(1):13-16.
-
Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon. Clin Infect Dis. 2019 09 27; 69(8):1440-1442.
-
The Primaquine Problem-and the Solution? Point-of-care Diagnostics for Glucose 6-Phosphate Dehydrogenase Deficiency. Clin Infect Dis. 2019 09 27; 69(8):1443-1445.
-
Five cases of Plasmodium vivax malaria treated with artemisinin derivatives: the advantages of a unified approach to treatment. Infection. 2019 Aug; 47(4):655-659.
-
Tafenoquine - A Radical Improvement? N Engl J Med. 2019 01 17; 380(3):285-286.
-
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria. N Engl J Med. 2019 01 17; 380(3):215-228.
-
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. N Engl J Med. 2019 01 17; 380(3):229-241.
-
Mixed Infection with Plasmodium falciparum and Plasmodium ovale in a Returned Traveller: the First Case in Korea. J Korean Med Sci. 2019 Jan 21; 34(3):e23.
-
Primaquine for all: is it time to simplify malaria treatment in co-endemic areas? Lancet Infect Dis. 2019 01; 19(1):10-12.
-
Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs. J Antimicrob Chemother. 2018 11 01; 73(11):3102-3113.